Biotechnology News

February 24, 2012

TRENTON, N.J.--(BUSINESS WIRE)--BioNJ, New Jersey’s biotechnology industry trade association, will host its biggest and most interactive event to date for companies involved in diagnostics and personalized medicine on March 14.

February 24, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB:CBIS.OB - News) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to announce Dr. Moe Afaneh, Pharm D., MBA, NRCC, RNC has...

February 24, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. to Participate in Upcoming 2012 Healthcare Conferences

February 24, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the Citi 2012 Global Health Care Conference in New York. Lesley Russell Cooper, SVP, R&D Global Branded Products, will present on...

February 24, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluxion Biosciences, a privately held drug discovery tools company, announced today that it has added 4 new senior management positions and expanded sales and technical support globally. The new...

February 24, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that Anthony S. Marucci, President and Chief Executive Officer of Celldex Therapeutics, Inc., will present at the Citi 2012 Global Health Care Conference...

February 24, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today announced the company’s lead compound, cabozantinib, is highlighted in a new peer-reviewed publication demonstrating that simultaneous inhibition of MET and VEGF...

February 24, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will present at the RBC Capital Markets’ Healthcare Conference on Wednesday, February 29, at 12:00 p.m. ET. The conference will be held at...

February 24, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Vertex will webcast its presentation at the 32nd Annual Cowen Health Care Conference on Tuesday, March 6, 2012 at 11:20 a.m. EST and at...

February 24, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced the pricing of an underwritten public offering of 10,500,000 shares of its common stock, offered at a price to the public of $3.85 per share for an...

February 24, 2012

EVERETT, Wash.--(BUSINESS WIRE)--SNBL USA is hosting a session entitled “Juvenile Preclinical Safety Evaluations of Biopharmaceuticals: Combining Data from Repeat Dose General and Pre/Postnatal Toxicology Studies.”

February 24, 2012

SHEFFIELD, England--(BUSINESS WIRE)--Simcyp acquired by Certara

February 24, 2012

ST. LOUIS--(BUSINESS WIRE)--Certara™ to acquire Simcyp Ltd, adding powerful preclinical research capability to translational science initiatives with Simcyp’s platform for predicting the fate of drugs in virtual populations.

February 24, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--RainDance Technologies to Update Investment Community on Business Growth and New Product Launches at Citi Global Health Care Conference

February 24, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Natera, formerly known as Gene Security Network, today announced that the company is scheduled to present at the Citi 2012 Global Health Care Conference at 4 p.m. EST on Monday, February 27, 2012, at the...

February 24, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) announced today that management will present a company overview on February 29, 2012 at the Citi 2012 Global Health Care Conference in New York. The GTx presentation will begin at 9:00 a.m...

February 24, 2012

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI), a developer of innovative stem cell technologies for neurodegenerative disorders, announced that NurOwn™, its autologous stem cell therapy for...

February 24, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--SPECTRUM PHARMACEUTICALS TO PRESENT AT THE CITI 2012 GLOBAL HEALTH CARE AND THE RBC CAPITAL MARKETS HEALTH CARE CONFERENCES

February 24, 2012

AUCKLAND, New Zealand--(BUSINESS WIRE)--Biomatters, the creators of Geneious, appoint NGS Leader Karin Fredrikson as Vice President of US Operations. Karin previously worked at 454 Sequencing, a Roche Company.

February 24, 2012

NEW YORK & DUBLIN--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX), an international pharmaceutical manufacturer and marketer, today announced that it has been granted European Medicines Agency (EMA) approval to market Colobreathe dry...

February 24, 2012

LUND, Sweden & PARIS--(BUSINESS WIRE)--Regulatory News: Active Biotech’s (NASDAQ OMX NORDIC: ACTI) and Ipsen’s (Paris:IPN) (Euronext: IPN; ADR: IPSEY) castrate resistant prostate cancer project, TASQ, will be presented at the 27th Annual EAU...

February 24, 2012

MOSCOW & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles and Russian Venture Company Biofund, a Russian-based investment firm, have allied to expand clinical development services in the Russian Federation, the world's ninth most...

February 23, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (Nasdaq: CLVS) will announce its fourth quarter and year-end 2011 financial results on Thursday, March 8, 2012, before the open of the U.S. financial markets.

February 23, 2012

TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that it will host a conference call to discuss fourth quarter and full year 2011 operating and financial...

February 23, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced it will report audited consolidated financial results for the fourth quarter and year ended December 31, 2011 after the U.S. financial markets close on...

February 23, 2012

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River to present at upcoming investor conferences

February 23, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that it is offering shares of its common stock in an underwritten public offering. All of the shares in the offering will be sold by Celldex. The offering...

February 23, 2012

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix International N.V. (NASDAQ:OFIX) (the Company) today announced its results for the fourth quarter and year ended December 31, 2011. Net sales were $151.5 million and $579.0 million for the fourth...

February 23, 2012

ARLINGTON, Tenn.--(BUSINESS WIRE)--Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company and a leading provider of surgical solutions for the foot and ankle market, today reported financial results for its fourth...

February 23, 2012

ARDEN HILLS, Minn.--(BUSINESS WIRE)--IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its fourth quarter and year...

February 23, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (NASDAQ:SGEN) today announced that management will present at the following upcoming investor conferences. RBC Capital Markets’ 2012 Global Healthcare Conference Tuesday, February 28, 2012...

February 23, 2012

WINTER PARK, Fla.--(BUSINESS WIRE)--Ascendx Spine™ (www.ascendxspine.com) announced today that it has received FDA clearance to market in the United States its Acu-Cut...

February 23, 2012

NEW YORK--(BUSINESS WIRE)--In the course of its ongoing surveillance efforts, Fitch upgrades to 'BB' from 'BB-' the following bond issued on behalf of Appalachian Regional Healthcare (ARH): --$61,545,000 Kentucky Economic Development Finance...

February 23, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) today announced the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2011. The Form 20-F is available on Elan's website at...

February 23, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today that it will provide access via the World Wide Web to its presentation at the RBC Capital Markets' Healthcare Conference. The live presentation will occur at 11:...

February 23, 2012

DENVER--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB:CBIS.OB - News) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products is monitoring the outstanding progress of the 3rd Self-Medicated Cannabis Patient...

February 23, 2012

PETAH-TIKVA, Israel--(BUSINESS WIRE)--Can-Fite BioPharma announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Status for its drug candidate, CF102, for the treatment of hepatocellular carcinoma

February 23, 2012

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/...

February 23, 2012

NISKAYUNA, N.Y.--(BUSINESS WIRE)--GE and InDevR scientists developing breakthrough device to improve the diagnosis of flu at the point-of-care.

February 23, 2012

TOKYO--(BUSINESS WIRE)--Asia's largest bio event held annually in Tokyo: INT'L BIO FORUM & BIO EXPO JAPAN will be renewed as "BIO tech 2012", which consists of Partnering, Conference and Exhibition.

February 23, 2012

BOSTON--(BUSINESS WIRE)--Maxwell Biotech Venture Fund (MBVF), the first Russian venture for the life sciences sector, opens office in Boston along with RVC USA Inc.

February 23, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Precise Biometrics’ (STO:PREC) partner community continues to grow with Thursby partnership Precise Biometrics today announced a partnership with Thursby Software, further enhancing Thursby’s security...

February 23, 2012

MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE: OPK) today announced that senior management will present at the Citi 2012 Global Health Care Conference on Monday, February 27, 2012 at 4:00 PM EST. The conference will be held at The Waldorf...

February 23, 2012

SILVER SPRING, Md.--(BUSINESS WIRE)--Nuvilex, Inc. (NVLX), reports associate SG Austria presented the success with living cell encapsulation at Cell Line Development and Engineering Asia.

February 23, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Allenex AB (STO:ALNX): For the fourth quarter, October - December · Net sales for the quarter were SEK 27.5 million (20.0), an increase of 37.5 percent year on year. The quarter’s results included full...

February 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company announced today the European Medicines Agency has accepted the filing of the marketing authorization application for once-daily oral teriflunomide for the treatment of MS.

February 23, 2012

CAMARILLO, Calif.--(BUSINESS WIRE)--PBS Biotech®, the leading supplier of novel single-use bioreactors, announces that Andrew Gengos has joined its Advisory Board.